FEB 27, 2019 10:30 AM PST

Synthetic Antibodies - The Emerging Field of "Aptamers" in Diagnostics and Drug Discovery

Presented at: Drug Discovery 2019
Speaker
  • President & CEO, Aptagen, LLC
    Biography
      Dr. Caltagirone is the President & CEO of Aptagen and has over 25 years of research and business experience in start-ups. A native of York, PA, he began his studies at the University of the Sciences in Philadelphia followed by a Ph.D. in neuroscience from Drexel University. He completed his thesis on "Proton-Sensitive Ribozyme Switches with Molecular Memory" at Yale University, and has several patents and publications under his name.

    Abstract

    An aptamer (also known as a synthetic antibody) is a stable DNA, RNA, or peptide ligand that binds with high affinity and specificity to targets such as small molecules, peptides, proteins, biomarkers, cells, and tissues. Typical aptamer affinities are in the nanomolar to picomolar range for several target types.  However, unlike the traditional antibody, aptamers have impressive specificities against target antigens, thereby eliminating cross-reactivity with closely related targets and avoiding false-positive results.  A classic example is an aptamer that exhibits greater than 10,000-fold binding affinity for theophylline over caffeine, which differ from one another in structure by only a single methyl group. Additional benefits of aptamers include: manufacturing costs and time are all lower compared to that of monoclonal antibody production. Once the aptamer (nucleic acid) sequence is known, the aptamer can be easily synthesized using a DNA (oligo) synthesizer.  These aptamer oligos are easy to label with reporters, enzymes, or fluorescent tags. In addition, aptamers can be engineered into molecular switches or apta-switches for signal generation in a drug discovery-based assay or to produce an output in a diagnostic test.

    Learning Objectives: 

    1. To learn how Aptamers are used in Diagnostics 
    2. To learn how Aptamers are used in Drug Discovery


    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    APR 01, 2021 8:00 AM PDT
    C.E. CREDITS
    APR 01, 2021 8:00 AM PDT
    Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    FEB 27, 2019 10:30 AM PST

    Synthetic Antibodies - The Emerging Field of "Aptamers" in Diagnostics and Drug Discovery

    Presented at: Drug Discovery 2019

    Specialty

    Immunology

    Animal Research

    Gene Sequencing

    Cancer Diagnostics

    Dna Sequencing

    Oncology

    Biomarkers

    Protein

    Cell Culture

    Cancer Research

    Research

    Dna

    Research And Development

    Clinical Diagnostics

    Immuno-Oncology

    Geography

    North America40%

    Asia40%

    Europe20%

    Registration Source

    Website Visitors100%

    Job Title

    Research Scientist40%

    Student20%

    Educator/Faculty20%

    Medical Laboratory Technician20%

    Organization

    Academic Institution60%

    Pharmaceutical Company20%

    Manufacturer - Other20%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more